Analyze 60-day results of the COVID-19 ARDS trial
Delivered after the deadline (30 days after the deadline)
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 1 Feb 2021
- Due
- 31 Mar 2021
- Delivered
- 30 Apr 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“When the 60-day results of the COVID-19 ARDS trial become available during Q1 2021, they will be analysed by Mesoblast and Novartis”
What we found
Evidence strength A What the grades mean
Mesoblast announced the 60-day results of the COVID-19 ARDS trial on April 30, 2021, which occurred after the Q1 2021 deadline.
-
A Mesoblast Ltd. 6-K filed 2021-05-03
“April 30 and New York, USA; April 29, 2021: Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, today announced the 60 day results from the randomized controlled trial” ✓ confirmed on the page
Market reaction: the shares moved -4.9% against the S&P 500 over the three sessions around the disclosure (30 Apr 2021 to 5 May 2021). What this measures
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Analyze
- Deliverable
- COVID-19 ARDS trial 60-day results analysis
- Language
- Firm (“will”, “on track to”)
- In the company’s control
- High
- Specificity
- High
- Depends on
- Partner
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Mesoblast Ltd.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-MESO-022752 · Corrections policy